Psychopharmacologic Management in Attention Deficit Hyperactivity Disorder (ADHD), Executive Functioning, and other Neurodevelopmental Disorders
David I. Driver, M.D.
Please Plan to Arrive by 8:30am
We will start promptly at 8:45am
This CE class is offered via live webinar as well as in-person. Please select the ticket type that you prefer.
This workshop will review varied approaches to the treatment of ADHD, Executive Functioning and other Neurodevelopmental Disorders with a focus on the discussion of the latest pharmacologic approaches. We will discuss the nuances of medication selection, and the fundamental principles of conducting a medication trial to determine effectiveness, with an emphasis on the importance of collaboration among the members of a treatment team.
Learning Objectives – what specific measurable skills will attendees leave with (list 3-4): (please use action words to describe what learners will be able to do, such as: list, describe, recite, explain, apply, demonstrate, utilize, assess, compare, etc.)
1. Describe the approach to the evaluation, diagnosis, and development of a treatment plan that includes the use of both non-pharmacologic and pharmacologic interventions.
2. Discuss various categories of pharmacologic interventions for ADHD, Executive Functioning, and other Neurodevelopmental Disorders, to include medications that are new on the market as well as those in various stages of development.
3. List the first- and second-line psychopharmacological medication choices for youth who present with ADHD.
4. Describe the selection of starting doses of pediatric psychopharmacological agents, approaches to titration plans, and components to an appropriate drug trial.
Dr. David I. Driver was born and raised in Los Angeles, California. He served in the United States Army as an Army Medic for 7 years on active duty and 5 years in the reserves. While in the Army he pursued his undergraduate degree, graduating from the University of Texas at San Antonio. Dr. Driver received his doctorate from the University of Saint Eustatius School of Medicine, completed his adult psychiatric training at Georgetown University Hospital, his child and adolescent psychiatry training at Children’s National Medical Center, and a research fellowship at the National Institute of Mental Health. Dr. Driver current serves at the director of Healthy Foundations Group in Bethesda, Maryland. In addition, he serves in various other consulting roles – NFL Program for Substance Abuse, University of Maryland Athletic Program, and Child Psychiatry Branch at the National Institute of Mental Health.
Please contact Veronica Raggi: email@example.com Continuing Education: 3 credits
Alvord, Baker & Associates, LLC is approved by the American Psychological Association to sponsor continuing education for psychologists.
Alvord, Baker & Associates, LLC maintains responsibility for each program and its content.
Alvord, Baker & Associates, LLC is authorized by the Maryland Board of Social Work Examiners as a sponsor of Continuing Education. A certificate for Category 1 credits will be awarded at the completion of each workshop.
If Alvord,Baker & Associates, LLC decides to cancel the class, all registrants will receive a full refund. Through Friday, October 28, 2016, registrants of workshop who need to cancel for any reason will receive a refund of 90% of their registration fee.
Cancellation requests must be received no later than November 25, 2016 either by phone 301-593-6554 x40 or by email:firstname.lastname@example.org. Be sure to include your name, address and contact information as provided in your registration information. No refunds will be issued for any reason after November 25, 2016.
Have questions about this seminar? Contact Alvord, Baker & Associates, LLC